Innovating Post-transplant Care: Employing Donor-Derived Cell-Free DNA measured by SNP for Early Graft Dysfunction Detection"
- Conditions
- Heart transplant, Lung Transplant, Liver transplant, Kidney Transplant, Pancreas Transplant
- Registration Number
- JPRN-UMIN000052656
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 420
Not provided
The provided information outlines certain exclusion criteria for the study: 1. Pregnancy: Pregnant individuals are excluded from participation. 2. Twin-to-Twin Transplants: Cases involving twin-to-twin transplants are not eligible. 3. History of Bone Marrow Transplant: Individuals with a history of bone marrow transplant are not included. 4. Multiple Organ Transplants: The study primarily focuses on single-organ transplant patients. However, exceptions are made for pancreas-kidney simultaneous transplant patients and liver-small intestine simultaneous transplant patients. 5. Re-transplantation: Patients who have undergone re-transplantation are excluded from the study. Note regarding Multiple Organ Transplants: The study allows for exceptions in cases of pancreas-kidney simultaneous transplant patients and liver-small intestine simultaneous transplant patients. These patients may be eligible for registration.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method